GlassScriptPhysician profile
Matthew A Kopplin
NPI 1598850984
$34,863.32
in general payments reported to CMS, 2019-2025
11 companies · $8,355 in 2025
The $8,355 reported for 2025 was more than what 86% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $5,248 · 2021: $5,946 · 2022: $1,834 · 2023: $101 · 2024: $3,147 · 2025: $8,355.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,621 · Travel and Lodging: $2,733 · Food and Beverage: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,621.38 |
| Travel and Lodging | $2,732.63 |
| Food and Beverage | $1,249.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medacta USA, INC. | $26,091.47 | 2019-2025 | Gmk Sphere, Nextar Knee, Mpact |
| Restor3d, INC. | $4,995.52 | 2024-2025 | |
| Stryker Corporation | $1,485.33 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $1,158.66 | 2019-2025 | Avenir, Persona, Rosa |
| Orthalign INC | $773.67 | 2025 | Orthalign Plus |
| Davol INC. | $115.10 | 2025 | Surgiphor, Arista |
| Heron Therapeutics, INC. | $104.67 | 2022-2024 | Zynrelef |
| Avanos Medical | $72.93 | 2019-2021 | |
| Innovation Technologies INC | $35.10 | 2025 | Irrisept |
| Medtronic USA, INC. | $20.00 | 2020 | |
| Steelhead Surgical INC | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kopplin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.